Swiss drug maker Novartis AG has hiked its stake to 76.42 per cent in its Indian subsidiary Novartis India pursuant to the completion of open offer.
Novartis India in a filing to the Bombay Stock Exchange said that the promoters have acquired 8,147,365 shares, or 25.49 per cent stake, in the company at a price of Rs 450 a piece, aggregating to over Rs 366.63 crore.
In March, the Swiss parent had made an open offer for an additional 39 per cent stake in its Indian unit.
However, only 25.49 per cent stake was tendered by the public shareholders. The open offer closed on June 8.
Novartis AG's holding in the company has increased to 2,44,24,802 shares, or 76.42 per cent, pursuant to the acquisition, from 50.9 per cent stake earlier. DSP Merrill Lynch Ltd acted as the manager to the offer.
Shares of Novartis India closed at Rs 428.65, down 0.08 per cent on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app